fda glp-1 compounding New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compound versions of GLP-1 drugs
Description
Sign up for the Bodywork newsletter.

This research was supported by National Natural Science Foundation of China (82271112)

PMID 33567185

LIV Body's program is designed to pair potential medication use with lifestyle support, which aligns with how GLP-1 therapy is most effectively used clinically
Read what our members say or call Palm Desert at (760) 766-0934, La Quinta at (760) 509-1993, or Palm Springs at (760) 388-2638.

While protein stimulates GLP-1 production (beneficial), certain amino acid patterns may also affect DPP-4 expression
